Skip to main contentSkip to main content
Updating results

Patient

  • Updated

During a period when the Omicron coronavirus variant was dominant, severe outcomes for patients hospitalized with Covid-19 -- including ICU admission, ventilator use and death -- were less common than during Delta or the first winter surge, according to a study published Tuesday by the US Centers for Disease Control and Prevention.

  • Updated

Merck’s molnupiravir is not authorized for children because it might interfere with bone growth. It also isn't recommended for pregnant women …

  • Updated

THURSDAY, Dec. 23, 2021 (HealthDay News) -- Many Americans now have two oral antiviral pills that can be taken at home to treat a fresh case of COVID-19. The U.S. Food and Drug Administration on Thursday approved the emergency use of the molnupiravir pill from Merck for the treatment of mild-to-moderate COVID-19 in people who have just tested positive.

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News